Meeder Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-22,043
Closed -$3.9M 2696
2020
Q1
$3.9M Buy
22,043
+2,658
+14% +$500K 0.3% 77
2019
Q4
$3.71M Buy
19,385
+3,927
+25% +$708K 0.23% 102
2019
Q3
$2.6M Sell
15,458
-18,049
-54% -$2.94M 0.17% 118
2019
Q2
$5.61M Buy
33,507
+242
+0.7% +$33.5K 0.39% 71
2019
Q1
$4.87M Buy
33,265
+8,705
+35% +$1.26M 0.38% 74
2018
Q4
$3.28M Buy
24,560
+23,350
+1,930% +$3.83M 0.29% 84
2018
Q3
$230K Buy
+1,210
New +$222K 0.02% 488
2018
Q1
Sell
-1,398
Closed -$229K 1822
2017
Q4
$229K Sell
1,398
-4,796
-77% -$861K 0.02% 448
2017
Q3
$1.27M Buy
6,194
+1,693
+38% +$394K 0.14% 175
2017
Q2
$1.09M Buy
+4,501
New +$1.06M 0.1% 184
2016
Q4
Sell
-5,803
Closed -$1.34M 1096
2016
Q3
$1.34M Sell
5,803
-6,421
-53% -$1.57M 0.11% 203
2016
Q2
$2.83M Buy
+12,224
New +$2.82M 0.26% 76

Other funds holding AGN

Meeder Asset Management's AGN Position: Q2 2020 in Review

Meeder Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 22,043 shares — an estimated $3.9M sold.

Meeder Asset Management first reported a position in AGN in Q2 2016 and held it in 12 quarters. The position peaked at $5.61M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Meeder Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 22,043 Allergan plc shares in Q2 2020, an estimated $3.9M.
  • Meeder Asset Management first reported a position in Allergan plc in Q2 2016 and held it in 12 quarters.
  • Meeder Asset Management's Allergan plc position peaked at $5.61M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.